Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

8.95
+0.13001.47%
Volume:1.97M
Turnover:17.08M
Market Cap:1.43B
PE:-7.78
High:9.05
Open:8.77
Low:8.44
Close:8.82
Loading ...
Feb 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Correspondence

Form CORRESP - Correspondence